Bristol Myers, Bain Capital form new company to develop immunology drugs

Bristol Myers, Bain Capital form new company to develop immunology drugsSource: Reuters
أخبار الاستثمار والأسواق المالية من موقع Investing.com

Bristol Myers, Bain Capital form new company to develop immunology drugsSource: Reuters

Buffett's Berkshire to sell one-third of VeriSign stakeSource: Reuters

Insurance broker Brown & Brown's profit climbs on fee and commission growthSource: Reuters

Loandepot stock rises as founder Hsieh returns as permanent CEOSource: Investing.com

Steelmaker Nucor quarterly profit falls on rising raw material costsSource: Reuters

AECOM Technical Services secures $90 million DoD contract modificationSource: Investing.com

Olo said it rejected a $13/share unsolicited acquisition offerSource: Investing.com

Stantec Consulting Services wins $90 million DoD contract modificationSource: Investing.com
Verizon increases office days for hybrid workers, leases larger NYC space - WSJSource: Investing.com

General Dynamics secures $98 million contract extension from DoDSource: Investing.com